Search Within

Department of Medicine

Formats
  1. Journal Article (19572)
  2. Meeting Abstract (16038)
  3. Review (1147)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (235)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22311)
  2. Hematologic Malignancies, Division of (13264)
  3. Center for Hematologic Malignancies (11049)
  4. GSK Faculty (10640)
  5. Survivorship Research (9323)
  6. Division of Subspecialty Medicine (7531)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1068)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1043)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3721)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6456)
  2. Elsevier Inc. (4213)
  3. American Society of Hematology (4000)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2109)

More Publishers

Results (39594)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The SWI/SNF-related protein SMARCA3 is a histone H3K23 ubiquitin ligase that regulates H3K9me3 in cancer
    Journal Article

    Akano, I.; Hebert, J. M.; Tiedemann, R. L.; Gao, Q.; Xiao, Y.; Prescott, N. A.; Liu, Y.; Tan, K. S.; Bastle, R. M.; Ramakrishnan, A.; more...
    Molecular Cell (2025)

    Fulltext@MSK | Save
  • Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: Primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201
    Editorial

    Andreadis, C.; Bobek, O.; Hsi, E. D.; Fenske, T. S.; Stiff, P. J.; Hill, B. T.; Geyer, S. M.; Horwitz, M.; Khimani, F.; Little, R. F.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
    Guidelines

    Apperley, J. F.; Milojkovic, D.; Cross, N. C. P.; Hjorth-Hansen, H.; Hochhaus, A.; Kantarjian, H.; Lipton, J. H.; Malhotra, H.; Niederwieser, D.; Radich, J.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • The Lancet Commission on addressing the global hepatocellular carcinoma burden: Comprehensive strategies from prevention to treatment
    Review

    Chan, S. L.; Sun, H. C.; Xu, Y.; Zeng, H.; El-Serag, H. B.; Lee, J. M.; Schwartz, M. E.; Finn, R. S.; Seong, J.; Wang, X. W.; more...
    Lancet (2025)

    Fulltext@MSK | Save
  • Performance characteristics of an analytic model predicting retroperitoneal lymph node dissection pathology following first-line chemotherapy for patients with metastatic non-seminomatous germ cell tumors
    Journal Article

    Matulewicz, R. S.; Assel, M.; Vickers, A. J.; Jayalath, V. H.; Gold, S. A.; Funt, S. A.; Feldman, D. R.; Sheinfeld, J.
    Journal of Urology (2025)

    Fulltext@MSK | Save
  • Updated efficacy and safety from the phase 2 PHAROS study of encorafenib plus binimetinib in patients with BRAF V600E-mutant metastatic NSCLC—A brief report
    Journal Article

    Riely, G. J.; Ahn, M. J.; Clarke, J. M.; Dagogo-Jack, I.; Esper, R.; Felip, E.; Gelsomino, F.; Goldman, J. W.; Hussein, M.; Johnson, M.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • The 2025 American Association for Thoracic Surgery (AATS) expert consensus document: Surgical management of esophageal and gastroesophageal junction cancer
    Conference Paper

    Molena, D.; Sewell, M.; Maron, S. B.; Hofstetter, W.; Worrell, S.; Chen, K. N.; Enzinger, P. C.; Gerdes, H.; Kleinberg, L.; Murthy, S.; more...
    Mosby Elsevier (2025)

    Fulltext@MSK | Save
  • Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC
    Journal Article

    Rimassa, L.; Chan, S. L.; Sangro, B.; Lau, G.; Kudo, M.; Reig, M.; Breder, V.; Ryu, M. H.; Ostapenko, Y.; Sukeepaisarnjaroen, W.; more...
    Journal of Hepatology (2025)

    Fulltext@MSK | Save
  • Long-term survival and biomarker analysis evaluating neoadjuvant plus adjuvant relatlimab (anti-LAG3) and nivolumab (anti-PD1) in patients with resectable melanoma
    Journal Article

    Burton, E. M.; Milton, D. R.; Tetzlaff, M. T.; Wani, K.; Ross, M. I.; Postow, M. A.; Lazcano, R.; Glitza, I. C.; Wong, M. K.; Patel, S. P.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Efficacy and safety of avutometinib ± defactinib in recurrent low-grade serous ovarian cancer: Primary analysis of ENGOT-OV60/GOG-3052/RAMP 201
    Journal Article

    Banerjee, S. N.; Van Nieuwenhuysen, E.; Aghajanian, C.; D'Hondt, V.; Monk, B. J.; Clamp, A.; Prendergast, E.; Oaknin, A.; Ring, K.; Colombo, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save